Renal Failure Chronic Requiring Hemodialysis Clinical Trial
Official title:
A Randomized, Placebo-Controlled, Phase III Study of Dialysate Containing Soluble Ferric Pyrophosphate (SFP) in Chronic Kidney Disease Patients Receiving Hemodialysis: The Continuous Replacement Using Iron Soluble Equivalents (CRUISE 1) Study
The purpose of this study is to confirm the safety and efficacy of Soluble Ferric Pyrophosphate (SFP) dialysate solution in maintaining iron delivery for erythropoiesis in anemic adult patients with chronic kidney disease (CKD) receiving hemodialysis. Efficacy will be measured primarily by the change from baseline in hemoglobin (Hgb).
Screening: 2-3 weeks prior to enrollment in Stage 1.
Stage 1 (Run-In): 1-4 weeks depending on qualification for Stage 2.
Stage 2 (Randomized Blinded Treatment): 12 months unless withdrawn prematurely.
Stage 3 (Open-Label Treatment): The duration of Stage 2 plus Stage 3 is intended to be 18
months regardless of treatment assignment in Stage 2.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01947673 -
Mechanisms of Intradialytic Hypertension
|
N/A | |
Not yet recruiting |
NCT03634904 -
Serum Ceftazidime Concentrations in Hemodialysis Patients
|
N/A | |
Terminated |
NCT01982864 -
Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients.
|
Phase 4 | |
Completed |
NCT01448174 -
Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT01421771 -
Blood Pressure in Dialysis Patients
|
N/A | |
Completed |
NCT01722695 -
Performance Comparison of Revaclear With Larger Dialyzer
|
N/A | |
Withdrawn |
NCT01015313 -
Effects of Intensified Sodium Management in Hemodialysis Patients
|
N/A | |
Completed |
NCT02259413 -
Effect of an Exercise Rehabilitation Program on Symptoms in Hemodialysis
|
N/A | |
Not yet recruiting |
NCT02452788 -
Pharmaceutical Care in Ambulatory Hemodialysis Patients
|
N/A | |
Recruiting |
NCT01356563 -
Efficacy Study of Pharmacist Intervention on Medication-related Problems in Hemodialysis Patients
|
N/A | |
Completed |
NCT01181544 -
A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis
|
N/A | |
Completed |
NCT02285075 -
Temocillin Pharmacokinetic in Hemodialysis
|
Phase 4 | |
Completed |
NCT02825589 -
BIA-Guided Dry Weight Assessment on Sleep Quality in Chronic Hemodialysis Patients
|
N/A | |
Completed |
NCT00890045 -
Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study
|
N/A | |
Not yet recruiting |
NCT02264964 -
Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis
|
N/A | |
Terminated |
NCT01312441 -
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
|
Phase 4 | |
Completed |
NCT01214928 -
Hemodialysis Vitamin D Pilot
|
N/A | |
Completed |
NCT00967993 -
Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
|
Phase 2 | |
Completed |
NCT01981603 -
Transplant Navigator Dissemination
|
N/A | |
Completed |
NCT01578421 -
Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser
|
N/A |